CANY
DAVA icon

Caxton Associates (New York)’s Endava DAVA Stock Holding History

Caxton Associates (New York)’s Portfolio DAVA Stock Details DAVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,901
Closed -$2M – 554
2021
Q4 		$2M Buy
11,901
+4,035
+51% +$625K 0.2% 46
2021
Q3 		$1.07M Buy
7,866
+495
+7% +$63.9K 0.12% 92
2021
Q2 		$836K Buy
+7,371
New +$713K 0.09% 90
2020
Q4 		– Sell
-6,207
Closed -$392K – 176
2020
Q3 		$392K Hold
6,207
– – 0.04% 146
2020
Q2 		$300K Hold
6,207
– – 0.03% 260
2020
Q1 		$218K Buy
+6,207
New +$282K 0.04% 332

Other funds holding DAVA

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Caxton Associates (New York)'s DAVA Position: Q1 2022 in Review

Caxton Associates (New York) sold out of Endava (DAVA) in Q1 2022, closing a stake of 11,901 shares — an estimated $2M sold.

Caxton Associates (New York) first reported a position in DAVA in Q1 2020 and held it in 6 quarters. The position peaked at $2M in Q4 2021. 196 funds tracked by Wall St. Rank hold DAVA as of Q1 2022.

  • Caxton Associates (New York) reported no remaining Endava position as of Q1 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 11,901 Endava shares in Q1 2022, an estimated $2M.
  • Caxton Associates (New York) first reported a position in Endava in Q1 2020 and held it in 6 quarters.
  • Caxton Associates (New York)'s Endava position peaked at $2M in Q4 2021.
  • 196 funds tracked by Wall St. Rank held Endava as of Q1 2022.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.